AORT vs BBNX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

AORT

39.0
AI Score
VS
AORT Wins

BBNX

33.1
AI Score

Investment Advisor Scores

AORT

39score
Recommendation
SELL

BBNX

33score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric AORT BBNX Winner
Forward P/E 204.0816 0 Tie
PEG Ratio 181.5 0 Tie
Revenue Growth 11.3% 37.8% BBNX
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 39.0/100 33.1/100 AORT
Profit Margin -0.7% -61.3% AORT
Beta 1.00 1.00 Tie
AI Recommendation SELL EXTENDED BBNX

Relative Price Performance (Last 90 Days)

AORT 1M: +12.3% · 3M: +23.3% BBNX 1M: +18.1% · 3M: +79.5%

Current Technical Phase

AORT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.1% over 20 days), RSI 57

RSI (14): 57.3 · Price: $28.08

BBNX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (13.1% over 20 days), RSI 63

RSI (14): 63.0 · Price: $19.05

Fundamentals Snapshot

Metric AORT BBNX
Market Cap
Forward P/E 35.9 -8.2
Trailing P/E
Revenue (TTM)
Revenue Growth 0.1% 0.4%
Gross Margin 0.6% 0.6%
Operating Margin 0.1% -0.8%
EPS -0.06 -1.56
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, AORT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.